KRAS and pancreatic neoplasm: CCAT2, the lncRNA that promotes colorectal cancer growth, metastasis, and chromosomal instability upregulates WNT and CMYC signaling when activated by the WNT pathway [250], but also by the KRAS-MEK axis in pancreatic cancer [251].